Cargando…

Factors Associated with Therapeutic Adherence in Multiple Sclerosis in Spain

PURPOSE: Adherence to disease-modifying therapies (DMTs) in multiple sclerosis (MS) is a complex and multidimensional phenomenon. Identifying the predictors of therapeutic adherence in MS will guide the design of interventions to improve health outcomes. Our aim was to assess the degree of adherence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soria, Cristina, Prieto, Lola, Lázaro, Esther, Ubeda, Amalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024534/ https://www.ncbi.nlm.nih.gov/pubmed/36941926 http://dx.doi.org/10.2147/PPA.S401962

Ejemplares similares

Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain
por: Morillo Verdugo, Ramón, et al.
Publicado: (2019)

Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
por: Fernández, Oscar, et al.
Publicado: (2012)

Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
por: Fernández, Oscar, et al.
Publicado: (2012)

Potentially inappropriate prescribing in institutionalised older patients in Spain: the STOPP-START criteria compared with the Beers criteria
por: Ubeda, Amalia, et al.
Publicado: (2012)

Therapeutic adherence and coping strategies in patients with multiple sclerosis: An observational study
por: Corallo, Francesco, et al.
Publicado: (2019)

Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and Spain
por: Almusalam, Noora, et al.
Publicado: (2019)

Medication economic burden of antidepressant non-adherence in Spain
por: Gutiérrez-Abejón, Eduardo, et al.
Publicado: (2023)

Impact on healthcare resource utilization of multiple sclerosis in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2017)

Adherence to healthy dietary pattern is associated with lower risk of multiple sclerosis
por: Keykhaei, Fatemeh, et al.
Publicado: (2022)

Adherence to disease-modifying therapies in patients with multiple sclerosis
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2018)

Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain
por: Saposnik, Gustavo, et al.
Publicado: (2021)

Adherence to Mediterranean Diet Is Associated with Multiple Sclerosis Severity
por: Guglielmetti, Monica, et al.
Publicado: (2023)

Information-Seeking Strategies of People with Multiple Sclerosis in Spain: The INFOSEEK-MS Study
por: Higueras, Yolanda, et al.
Publicado: (2022)

Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability
por: Casado, Virginia, et al.
Publicado: (2006)

Adherence to Disease-Modifying Therapies for Multiple Sclerosis
por: Higuera, Lucas, et al.
Publicado: (2016)

Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study
por: Fernández, O., et al.
Publicado: (2012)

Adherence to glatiramer acetate treatment for multiple sclerosis: the Brazilian experience
por: de Oliveira, Tatiana de Melo Gomes, et al.
Publicado: (2008)

Treatment adherence in multiple sclerosis: a survey of Belgian neurologists
por: Decoo, Danny, et al.
Publicado: (2015)

Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis
por: Zanga, Gisela, et al.
Publicado: (2021)

Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
por: Alosaimi, Fahad D, et al.
Publicado: (2017)

Predictors of Adherence to Multiple Clinical Preventive Recommendations among Adults with Diabetes in Spain
por: Jimenez-Trujillo, Isabel, et al.
Publicado: (2015)

Association between multiple sclerosis disease severity and adherence to disease-modifying therapies
por: Burkhard, Adam, et al.
Publicado: (2021)

The Impact of Comorbid Depression on Adherence to Therapy for Multiple Sclerosis
por: Tarrants, M., et al.
Publicado: (2011)

The Impact of Motor Disability and the Level of Fatigue on Adherence to Therapeutic Recommendations in Patients with Multiple Sclerosis Treated with Immunomodulation
por: Ślusarz, Robert, et al.
Publicado: (2021)

Persistence and adherence in multiple sclerosis patients starting glatiramer acetate treatment: assessment of relationship with care received from multiple disciplines
por: Jongen, Peter Joseph, et al.
Publicado: (2016)

Adherence to Therapy in Patients with Multiple Sclerosis—Review
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2022)

Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study
por: Pedrosa-Naudín, M. Aránzazu, et al.
Publicado: (2022)

Tuberculosis treatment adherence and fatality in Spain
por: Caylà, Joan A, et al.
Publicado: (2009)

Cost–effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain
por: Ginestal, Ricardo, et al.
Publicado: (2023)

Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain
por: Pombo-Suarez, Manuel, et al.
Publicado: (2021)

The Impact of Adherence to Disease-Modifying Therapies on Functional Outcomes in Veterans with Multiple Sclerosis
por: Rabadi, Meheroz H, et al.
Publicado: (2021)

Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain
por: Biagetti, Betina, et al.
Publicado: (2022)

Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis
por: Navas, Carlos, et al.
Publicado: (2018)

Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
por: Washington, Francesca, et al.
Publicado: (2021)

Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2017)

Risk Factors for Salmonella Detection in Commercial Layer Flocks in Spain
por: Samper-Cativiela, Clara, et al.
Publicado: (2023)

Medication adherence/persistence among patients with active multiple sclerosis in Finland
por: Lahdenperä, Sanni, et al.
Publicado: (2020)

Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain
por: Sempere, Angel P., et al.
Publicado: (2021)

Economic Impact of Low Adherence to COPD Management Guidelines in Spain
por: Miravitlles, Marc, et al.
Publicado: (2021)

Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis
por: Earla, Jagadeswara R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_96217bufrkafifqpceeo8tm3dg